Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00041730
Status:
UNKNOWN
Last Update Posted:
2009-09-30
First Post:
2002-07-15
Brief Title:
Rituxan Plus FavId Idiotype Vaccine for Low-grade Non-Hodgkins Lymphoma
Sponsor:
Favrille
Organization:
Favrille
Organization Data
Organization:
Favrille
Class:
INDUSTRY
Study ID:
FavId-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Favrille
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None